DARK SECRETS: 51 | Vintage Vibes

Purdue Pharma plan moves forward despite challenge from opioid victim

Plaintiff says company’s bid to exit bankruptcy omits US government plan to seize $225m that should go to victims

The Guardian - US · Jun 25, 2025

Louisiana files lawsuits alleging pharmaceutical giant CVS deceived customers in text messages

Louisiana accused pharmaceutical giant CVS of using its dominant market position to abuse customer information, drive up drug costs and unfairly undermine independent pharmacies

The Independent UK · Jun 24, 2025

RFK Jr grilled on vaccine policies and healthcare fraud in bruising House hearing

US health secretary faced hours of questioning over budget cuts and accusations he lied to senators

The Guardian - US · Jun 24, 2025

Ocugen (OCGN) Shares Slide Following Merger Agreement: What's Going On?

Shares of Ocugen Inc (NASDAQ:OCGN) are trading lower by more than 8% Monday afternoon. The company earlier announced a definitive agreement to merge its subsidiary OrthoCellix with Carisma Therapeutics in an all-stock deal.

Benzinga · Jun 23, 2025

CorMedix Stock Hits New 52-Week High On Updated Guidance: The Details

CorMedix Inc (NASDAQ:CRMD) shares are hitting new 52-week highs on Monday after the company raised its sales guidance for the second quarter.

Benzinga · Jun 23, 2025

Purdue Pharma's $7B opioid settlement plan could get votes from victims and cities

A judge could decide Friday whether to advance OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids

The Independent UK · Jun 20, 2025

Marjorie Taylor Greene Buys Stocks Focusing on Tech, Energy, and a Biotech Firm That Recently Received FDA Approval for HIV Drug

US Congress member Marjorie Taylor Greene purchased shares of Adobe, Netflix, Snowflake, ServiceNow, NextEra Energy, and Gilead Sciences on 6th June.

International Business Times UK · Jun 20, 2025

Why This Chinese Herbal Medicine Stock Backed by BlackRock and Morgan Stanley Gained 50,000% in 6 Months Despite Posting Losses

Regecell BioScience Holding shares jumped 49,637% in the past six months on seemingly no news. The company develops traditional Chinese medicines to treat ADHD.

International Business Times UK · Jun 19, 2025

Shares of This Tiny Herbal Medicine Company With No Profits Rallies 72,000%, Boosts CEO Wealth to $25 Billion

Regencell Bioscience Holding stock continues its blistering rally despite recording no profits from its traditional herbal medicines to treat ADHD since going public in 2021.

International Business Times UK · Jun 18, 2025

Sarepta Drops 42% on Fatalities; Markets Eye Solid Biosciences

After a second patient passed away, Sarepta Therapeutics crashed. Solid Biosciences rose over 10% in response. Wall Street sees big upside in both names.

MarketBeat · Jun 18, 2025